PTC Therapeutics, Inc. (PTCT)
71.02
+1.20
(+1.72%)
USD |
NASDAQ |
Aug 24, 16:00
71.02
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Price : 71.02 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 70.54 | 71.36 | 69.79 | 69.82 | 674739.0 |
| Aug 20, 2026 | 73.05 | 73.56 | 70.46 | 70.52 | 802507.0 |
| Aug 19, 2026 | 73.72 | 74.02 | 72.22 | 73.67 | 1.515M |
| Aug 18, 2026 | 72.86 | 74.03 | 72.22 | 72.63 | 731633.0 |
| Aug 17, 2026 | 71.70 | 73.02 | 71.24 | 72.88 | 985769.0 |
| Aug 14, 2026 | 71.58 | 72.13 | 70.85 | 71.70 | 564331.0 |
| Aug 13, 2026 | 73.14 | 73.34 | 71.69 | 71.97 | 697348.0 |
| Aug 12, 2026 | 73.23 | 74.22 | 72.18 | 72.64 | 976043.0 |
| Aug 11, 2026 | 75.00 | 75.00 | 72.86 | 73.70 | 763595.0 |
| Aug 10, 2026 | 72.77 | 74.75 | 72.48 | 74.63 | 826179.0 |
| Aug 07, 2026 | 71.71 | 73.37 | 70.95 | 73.31 | 963179.0 |
| Aug 06, 2026 | 68.99 | 71.04 | 68.99 | 70.85 | 928898.0 |
| Aug 05, 2026 | 69.21 | 70.19 | 68.50 | 69.21 | 1.103M |
| Aug 04, 2026 | 69.27 | 69.80 | 67.51 | 69.10 | 1.421M |
| Aug 03, 2026 | 67.18 | 68.73 | 66.07 | 68.12 | 1.368M |
| Jul 31, 2026 | 70.92 | 73.72 | 64.57 | 68.01 | 4.330M |
| Jul 30, 2026 | 73.39 | 76.18 | 73.39 | 75.52 | 1.375M |
| Jul 29, 2026 | 74.85 | 76.46 | 73.61 | 74.49 | 1.174M |
| Jul 28, 2026 | 75.64 | 76.17 | 72.62 | 75.39 | 1.488M |
| Jul 27, 2026 | 77.62 | 79.33 | 75.72 | 75.80 | 1.853M |
| Jul 24, 2026 | 79.33 | 79.40 | 76.59 | 76.82 | 838164.0 |
| Jul 23, 2026 | 77.45 | 79.53 | 77.27 | 78.45 | 759374.0 |
| Jul 22, 2026 | 77.58 | 79.53 | 77.22 | 78.40 | 583883.0 |
| Jul 21, 2026 | 79.50 | 80.56 | 77.53 | 78.50 | 1.146M |
| Jul 20, 2026 | 78.78 | 79.70 | 77.42 | 78.01 | 954314.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Insmed, Inc. | 124.03 |
| Madrigal Pharmaceuticals, Inc. | 511.84 |
| Protagonist Therapeutics, Inc. | 154.70 |
| Biogen, Inc. | 218.11 |
| BioMarin Pharmaceutical, Inc. | 65.04 |
Price Related Metrics
| PS Ratio | 6.026 |
| Earnings Yield | -0.84% |
| Market Cap | 5.918B |
| Operating PE Ratio | 52.07 |